BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 15189743)

  • 1. Leflunomide in the treatment of rheumatoid arthritis.
    Li EK; Tam LS; Tomlinson B
    Clin Ther; 2004 Apr; 26(4):447-59. PubMed ID: 15189743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leflunomide versus methotrexate: a comparison of the European and American experience.
    Schiff MH
    Scand J Rheumatol Suppl; 1999; 112():31-5. PubMed ID: 10668525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.
    Strand V; Cohen S; Schiff M; Weaver A; Fleischmann R; Cannon G; Fox R; Moreland L; Olsen N; Furst D; Caldwell J; Kaine J; Sharp J; Hurley F; Loew-Friedrich I
    Arch Intern Med; 1999 Nov; 159(21):2542-50. PubMed ID: 10573044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leflunomide: a review of its use in active rheumatoid arthritis.
    Prakash A; Jarvis B
    Drugs; 1999 Dec; 58(6):1137-64. PubMed ID: 10651393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Sharp JT; Strand V; Leung H; Hurley F; Loew-Friedrich I
    Arthritis Rheum; 2000 Mar; 43(3):495-505. PubMed ID: 10728741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leflunomide in monotherapy of rheumatoid arthritis: meta-analysis of randomized trials.
    Golicki D; Newada M; Lis J; Pol K; Hermanowski T; Tłustochowicz M
    Pol Arch Med Wewn; 2012; 122(1-2):22-32. PubMed ID: 22353705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.
    Goldenberg MM
    Clin Ther; 1999 Nov; 21(11):1837-52; discussion 1821. PubMed ID: 10890256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.
    Kremer JM; Genovese MC; Cannon GW; Caldwell JR; Cush JJ; Furst DE; Luggen ME; Keystone E; Weisman MH; Bensen WM; Kaine JL; Ruderman EM; Coleman P; Curtis DL; Kopp EJ; Kantor SM; Waltuck J; Lindsley HB; Markenson JA; Strand V; Crawford B; Fernando I; Simpson K; Bathon JM
    Ann Intern Med; 2002 Nov; 137(9):726-33. PubMed ID: 12416946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of leflunomide in active rheumatoid arthritis.
    Smolen JS; Emery P
    Rheumatology (Oxford); 2000 Jun; 39 Suppl 1():48-56. PubMed ID: 11001380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide for treating rheumatoid arthritis.
    Osiri M; Shea B; Robinson V; Suarez-Almazor M; Strand V; Tugwell P; Wells G
    Cochrane Database Syst Rev; 2003; 2002(1):CD002047. PubMed ID: 12535423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leflunomide: a novel DMARD for the treatment of rheumatoid arthritis.
    Alldred A; Emery P
    Expert Opin Pharmacother; 2001 Jan; 2(1):125-37. PubMed ID: 11336574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis.
    Emery P; Breedveld FC; Lemmel EM; Kaltwasser JP; Dawes PT; Gömör B; Van Den Bosch F; Nordström D; Bjorneboe O; Dahl R; Horslev-Petersen K; Rodriguez De La Serna A; Molloy M; Tikly M; Oed C; Rosenburg R; Loew-Friedrich I
    Rheumatology (Oxford); 2000 Jun; 39(6):655-65. PubMed ID: 10888712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
    Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
    Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
    Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease modification in rheumatoid arthritis with leflunomide.
    Emery P
    Scand J Rheumatol Suppl; 1999; 112():9-14. PubMed ID: 10668522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
    Smolen JS; Kalden JR; Scott DL; Rozman B; Kvien TK; Larsen A; Loew-Friedrich I; Oed C; Rosenburg R
    Lancet; 1999 Jan; 353(9149):259-66. PubMed ID: 9929017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
    Lee SS; Park YW; Park JJ; Kang YM; Nam EJ; Kim SI; Lee JH; Yoo WH; Lee SI
    Scand J Rheumatol; 2009; 38(1):11-4. PubMed ID: 19191187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis.
    Alfaro-Lara R; Espinosa-Ortega HF; Arce-Salinas CA;
    Reumatol Clin (Engl Ed); 2019; 15(3):133-139. PubMed ID: 28867467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of the new DMARD leflunomide: comparison to placebo and sulfasalazine in active rheumatoid arthritis.
    Smolen JS
    Scand J Rheumatol Suppl; 1999; 112():15-21. PubMed ID: 10668523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.